DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice
- Brain Res. 1997 Mar 28;752(1-2):327-30. doi: 10.1016/s0006-8993(97)00079-6.
- 1. Department of Pharmacology, The Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Japan.
The depolarization induced by DCG-IV, a potent agonist for Group II Metabotropic Glutamate Receptors (Group II mGluRs), was depressed by selective antagonists for NMDA receptors in the rat cortical slice, but was not affected even by a high concentration of a selective antagonist for Group II mGluRs. DCG-IV caused depolarization more effective than NMDA in a dose-dependent manner with a threshold concentration of 3 microM in rat cortical slices, while DCG-IV was less active than NMDA in rat spinal cords. These actions should be carefully considered particularly when DCG-IV is used as an agonist for mGluRs in vivo.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: mGluRResearch Areas: Neurological Disease